Alpine 4 Holdings Inc (ALPP)

[arch1inc]

I think a lot of people are taking this LPC deal the wrong way. Tickers that use LPC in the past have needed fast cash to fix bad issues with debt and or paying off immediate financing of large events. These tickers tend to not have revenue and won't be generating revenue for a while. As seen by these tickers: Mar 20 UMRX open .42 Current stock price .458 - https://www.biospace.com/article/releases/unum-therapeutics-announces-common-stock-purchase-agreement-for-up-to-25-million-with-lincoln-park-capital/
Mar 27 ECOR open .4489 Current stock price .9554 https://www.massdevice.com/electrocore-selling-up-to-25m-in-stock-to-lincoln-park/
Mar 30 EQ open 2.94 current stock price 3.31 https://ir.equilliumbio.com/news-releases/news-release-details/equillium-announces-common-stock-purchase-agreement-15-million
Dec 27 MVIS .73 Current stock price .77 (was 1.82 3 days ago from run on news) https://picante.today/it/2019/12/28/125233/microvision-enters-into-16-million-common-stock-purchase-agreement-with-lincoln-park-capital/
Dec 18 2018 CFMS .4788 current stock price .9514 http://ir.conformis.com/news-releases/news-release-details/conformis-announces-common-stock-purchase-agreement
Nov 14 2019 AXRX open .63 current stock price .732 https://www.azurrx.com/investors/press-releases/2019/157-azurrx-biopharma-inc-announces-equity-purchase-agreement-for-up-to-15-million-with-lincoln-park-capital-fund-llc.html
Oct 25 2019 ALIM .63 Current stock price with split account 1.162 https://www.globenewswire.com/news-release/2019/10/25/1935679/0/en/Alimera-Sciences-Announces-Equity-Purchase-Agreement-for-up-to-20-Million-with-Lincoln-Park-Capital.html
LPC deals go right and best when the company does not need to utilize them. looking at recent 13-F filings, LPC is not even on the list for any of them. LPC deal is an option. not an obligation.